arrow_back Back to App

Easier Access to HIV Prevention Drugs and No Extra Costs.

This act aims to increase access to HIV prevention medications (PrEP and PEP) by ensuring their free coverage by most health insurance plans, including federal programs. It also prohibits discrimination in life, disability, and long-term care insurance due to taking these medications, and introduces educational campaigns and financial support programs for states and organizations.
Key points
HIV prevention medications (PrEP and PEP), along with related tests and doctor visits, will be free under most private and federal insurance plans (Medicare, Medicaid, CHIP, FEHBP, VA, TRICARE, Indian Health Service).
Life, disability, and long-term care insurers will not be able to deny coverage, raise premiums, or discriminate against individuals taking HIV prevention medications.
Public education campaigns will be established to increase awareness of PrEP and PEP, their effectiveness, and availability, and to combat stigma.
The act provides funding for states, territories, and organizations to create and support PrEP and PEP access programs, especially for uninsured or underinsured individuals.
Patient confidentiality will be ensured for individuals accessing PrEP under family plans, so other family members are not informed of their treatment.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3295
Sponsor: Sen. Smith, Tina [D-MN]
Process start date: 2021-12-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PrEP Access and Coverage Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_3295.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-12-01.

What are the main provisions?

Key points include:

  • HIV prevention medications (PrEP and PEP), along with related tests and doctor visits, will be free under most private and federal insurance plans (Medicare, Medicaid, CHIP, FEHBP, VA, TRICARE, Indian Health Service).
  • Life, disability, and long-term care insurers will not be able to deny coverage, raise premiums, or discriminate against individuals taking HIV prevention medications.
  • Public education campaigns will be established to increase awareness of PrEP and PEP, their effectiveness, and availability, and to combat stigma.
  • The act provides funding for states, territories, and organizations to create and support PrEP and PEP access programs, especially for uninsured or underinsured individuals.
  • Patient confidentiality will be ensured for individuals accessing PrEP under family plans, so other family members are not informed of their treatment.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Smith, Tina [D-MN].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health